These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3610904)

  • 1. Comparative in-vitro activity of cefodizime, cefpirome, carumonam and RU-28965 with other antimicrobials against anaerobes.
    Pascual A; Borobio V; Garcia-Iglesias MC; Perea EJ
    J Antimicrob Chemother; 1987 May; 19(5):701-3. PubMed ID: 3610904
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative in vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents against Neisseria gonorrhoeae.
    Khan MY; Gruninger RP; Nelson SM; Obaid SR
    Antimicrob Agents Chemother; 1983 Mar; 23(3):477-8. PubMed ID: 6303215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
    Bergeron MG; Lavoie GY; Boucher FD
    J Antimicrob Chemother; 1987 Nov; 20(5):663-9. PubMed ID: 3501422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial activity of carumonam and cefpirome on hospital strains resistant to gentamicin and cephalothin: comparison with other beta-lactam antibiotics, new fluoroquinolones, aminoglycosides and other antibiotics].
    Vanhoof R; Nyssen HJ; Nulens E; Roebben E; Hubrechts JM
    Pathol Biol (Paris); 1990 Jun; 38(6):634-7. PubMed ID: 2165238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of HR810 against 419 strict anaerobic bacteria.
    Jones RN; Gerlach EH
    Antimicrob Agents Chemother; 1985 Mar; 27(3):413-5. PubMed ID: 3994351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams].
    Le Noc P; Croize J; Le Noc D
    Pathol Biol (Paris); 1987 May; 35(5):451-6. PubMed ID: 3302846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of ceftriaxone against anaerobic bacteria.
    Rolfe RD; Finegold SM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):338-41. PubMed ID: 6100430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy.
    Nicoletti G; Blandino G; Cocuzza G; Dainelli B; Maida A; Debbia E; Schito G
    Chemotherapy; 1996; 42(2):100-6. PubMed ID: 8697884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of carumonam with gentamicin and other beta-lactam antimicrobials: a multicentric study.
    Martín-Luengo F; Baquero F; Cisterna R; García de Lomas J; García-Rodriguez J; Gobernado M; Gómez Lus R; Perea E; Piedrola G; Roy C
    Chemioterapia; 1987 Jun; 6(2 Suppl):115-6. PubMed ID: 3334551
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro activity of carumonam (RO 17-2301) on hospital bacteria].
    Soussy CJ; Le Van Thoi J; Duval JR
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):573-6. PubMed ID: 3534745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in-vitro activity and beta-lactamase stability of carumonam.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of intestinal anaerobes to new beta-lactam antibiotics.
    Bansal MB; Chuah SK; Thadepalli H
    Chemotherapy; 1984; 30(4):237-43. PubMed ID: 6744975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of third-generation cephalosporins. Anaerobes.
    Nichols RL; Smith JW
    Hosp Pract (Off Ed); 1991; 26 Suppl 4():11-7; discussion 48. PubMed ID: 1918210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria.
    Borobio MV; Pascual A; Dominguez MC; Perea EJ
    Antimicrob Agents Chemother; 1986 Oct; 30(4):626-7. PubMed ID: 3466569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of selected antibiotics against anaerobes.
    Wexler HM; Finegold SM
    Clin Ther; 1987; 10 Suppl A():12-8. PubMed ID: 3690606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of carumonam.
    Fass RJ; Helsel VL
    Antimicrob Agents Chemother; 1985 Dec; 28(6):834-6. PubMed ID: 4083866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducing capacity and selection of resistant variants of cefpirome (HR 810) in comparison with other beta-lactam compounds.
    Stobberingh EE; Houben AW
    Chemotherapy; 1988; 34(6):490-6. PubMed ID: 3072153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
    Werner H; Heizmann W; Luft G
    Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.